Effects of rotigotine transdermal patch: A Synthesis of Findings from 29 Studies

  1. Home
  2. Effects of rotigotine transdermal patch
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of rotigotine transdermal patch: A Synthesis of Findings from 29 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of rotigotine transdermal patch: A Synthesis of Findings from 29 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major research findings

Rotigotine transdermal patch has been shown to be an effective treatment for a variety of neurological conditions, including Parkinson's disease and restless legs syndrome (RLS). Several studies have demonstrated its efficacy in improving motor and non-motor symptoms in Parkinson's disease patients, as well as reducing the severity of RLS symptoms. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 .

Rotigotine transdermal patch has also been shown to be effective in improving sleep disturbances in Parkinson's disease patients. 10 , 16 , 7 , 3 , 15 , 12 .

Rotigotine transdermal patch has been shown to be effective in improving swallowing difficulties in Parkinson's disease patients. 29 , 1 .

Benefits and Risks

Benefit Summary

Rotigotine transdermal patch has been shown to be an effective treatment for a variety of neurological conditions, including Parkinson's disease and restless legs syndrome (RLS), improving motor and non-motor symptoms, and reducing the severity of sleep disturbances. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 .

Risk Summary

Like other dopamine agonists, rotigotine transdermal patch has the potential to cause adverse effects, including impulse control disorders and addiction. 17 . Additionally, rotigotine transdermal patch may lead to side effects at the application site, such as rash. 18 .

Comparison between studies

Commonalities

Many studies have shown that rotigotine transdermal patch is effective in treating Parkinson's disease and RLS. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 .

Differences

Some studies have shown differences in the efficacy of rotigotine transdermal patch. For example, some studies suggest that rotigotine transdermal patch is effective in improving motor symptoms in Parkinson's disease patients, while others do not. 9 , 28 .

Consistency and Contradictions in Results

The results of research on rotigotine transdermal patch are generally consistent, indicating its effectiveness in treating Parkinson's disease and RLS. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 . However, research on the side effects of rotigotine transdermal patch is still ongoing. 17 .

Points to Note Regarding Real-World Application

Rotigotine transdermal patch has been proven effective in treating neurological conditions such as Parkinson's disease and RLS. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 . However, rotigotine transdermal patch, like other dopamine agonists, has the potential to cause impulse control disorders and addiction. 17 . Therefore, it is crucial to follow your doctor's instructions when using rotigotine transdermal patch.

Limitations of Current Research

The research on rotigotine transdermal patch is not yet complete. In particular, there is a shortage of studies on the long-term safety and effectiveness of rotigotine transdermal patch. Further research is also needed to accurately determine the incidence and severity of rotigotine transdermal patch side effects. 17 .

Future Directions for Research

Research is needed on the long-term safety and effectiveness of rotigotine transdermal patch, as well as studies to accurately determine the incidence and severity of side effects. 17 .

Conclusion

Rotigotine transdermal patch has been shown to be effective in treating neurological conditions such as Parkinson's disease and RLS. 9 , 10 , 6 , 21 , 2 , 5 , 26 , 28 , 22 , 27 , 20 , 29 , 12 , 3 , 23 , 14 , 8 , 16 , 7 , 19 , 15 , 11 , 1 , 25 , 17 , 18 , 24 , 13 . However, like other dopamine agonists, rotigotine transdermal patch has the potential to cause impulse control disorders and addiction. 17 . It is crucial to follow your doctor's instructions when using rotigotine transdermal patch.

Literature analysis of 29 papers
Positive Content
28
Neutral Content
0
Negative Content
1
Article Type
9
4
3
6
28
1.

Effects of the rotigotine transdermal patch versus oral levodopa on swallowing in patients with Parkinson's disease.

Author: HiranoMakito, IsonoChiharu, FukudaKanji, UenoShuichi, NakamuraYusaku, KusunokiSusumu

Effective dysphagia treatment
Limited evidence

This abstract discusses the controversial effects of oral levodopa and rotigotine transdermal patch on swallowing function in Parkinson's disease (PD). While levodopa's effects on swallowing are unclear, rotigotine appears to be effective. The authors suggest that continuous dopaminergic stimulation from rotigotine may be responsible for its beneficial effect, but further research is needed.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

2.

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.

Author: AntoniniA, BauerL, DohinE, OertelW H, RascolO, ReichmannH, SchmidM, SinghP, TolosaE, ChaudhuriK Ray

Improved motor function
Improved quality of life
Application site reactions
Headache
Nausea
Somnolence

Rotigotine did not show superior improvement in multi-domain NMSS total score compared to placebo. However, it showed numerically greater improvement in mood/apathy and miscellaneous domains.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living.

Author: SunWeibo, WangQingyong, YangTiansong, FengChuwen, QuYuanyuan, YangYan, LiChaoran, SunZhongren, AsakawaTetsuya

Improved motor performance
Improved sleep quality

Rotigotine transdermal patch (TP) significantly reduced movement symptoms, activities of daily living (ADL) limitations, and sleep disturbances in patients with Parkinson's disease (PD), with no added incidence of adverse events compared with placebo.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

6.

Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.

Author: RaederVanessa, BouraIro, LetaValentina, JennerPeter, ReichmannHeinz, TrenkwalderClaudia, KlingelhoeferLisa, ChaudhuriK Ray

NMS management
PD treatment
QoL improvement
NMS
Parkinson's disease

Rotigotine, a transdermal patch, can manage motor symptoms and a wide range of non-motor symptoms (NMS) in patients with Parkinson's disease (PD), potentially improving their health-related quality of life (QoL).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

7.

The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson's disease: a meta-analysis.

Author: FeiLu, ZhouDao, DingZheng-Tong

PD sleep disorder treatment

This study aims to conduct a meta-analysis of randomized controlled trials to assess the efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorder in Parkinson's disease (PD).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

8.

Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials.

Author: WangHao-Tian, WangLi, HeYi, YuGang

Improved neuropsychiatric symptoms
Improved quality of life

Rotigotine transdermal patch effectively improved neuropsychiatric symptoms and quality of life in patients with Parkinson's disease (PD). Significant improvements were observed in scores for the emotion/apathy, sleep/fatigue, and quality of life domains.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

9.

An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson's disease.

Author: MüllerThomas, TolosaEduardo, BadeaLetitia, AsgharnejadMahnaz, GriegerFrank, MarkowitzMichael, NondonfazXavier, BauerLars, TimmermannLars

Dopamine-substituting therapy

This real-world study investigated the long-term effectiveness of different dopamine-substituting drug therapies in patients with Parkinson's disease. The study found that all dopamine-substituting therapies were efficacious, with a safety profile consistent with that expected of dopaminergic treatments.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

10.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Author: Rosa-GriloMiguel, QamarMubasher A, TaddeiRaquel N, PagonabarragaJavier, KulisevskyJaime, SauerbierAnna, ChaudhuriK Ray

Sleep improvement

Parkinson's disease is a progressive neurological disorder that can cause sleep problems. This study discusses the use of rotigotine, a drug that is used to treat Parkinson's disease, to improve sleep. The study found that rotigotine was effective in improving sleep in patients with Parkinson's disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

11.

Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.

Author: ZhangZhen-Xin, LiuChun-Feng, TaoEn-Xiang, ShaoMing, LiuYi-Ming, WangJian, AsgharnejadMahnaz, XueHai-Bo, SurmannErwin, BauerLars

Improved PD symptoms

Rotigotine is a medication used to treat Parkinson's disease. This study investigated the efficacy and safety of rotigotine in Chinese patients with advanced-stage Parkinson's disease.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

12.

Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.

Author: BhidayasiriRoongroj, SringeanJirada, ChaiwongSuchapit, AnanChanawat, PenkeawNuntiwat, LeaknokAmarinee, BoonpangKamolwan, SaksornchaiKarn, RattanachaisitWatchara, ThanawattanoChusak, JagotaPriya

Nocturnal symptom improvement

Rotigotine patches significantly improve nocturnal symptoms in patients with Parkinson's disease, as assessed using objective measures and clinical rating scales.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

13.

Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective.

Author: ChungSun Ju, AsgharnejadMahnaz, BauerLars, BenitezArturo, BoroojerdiBabak, HeidbredeTanja, LittleAllison, KimHan Joon

Improved treatment options
Symptom control

This review examines the evidence on switching from oral dopamine receptor agonists (DAs) to rotigotine transdermal patch in patients with Parkinson's disease (PD) and restless legs syndrome (RLS). It summarizes available data on dose equivalency, switching schedules, safety, tolerability, and efficacy, providing a suggested tool for clinicians.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

15.

Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease.

Author: WangYan, YangYuechang, WuHuijuan, LanDanmei, ChenYing, ZhaoZhongxin

Improved RBD symptoms

This prospective open-label study of 11 Parkinson’s disease (PD) patients with untreated REM sleep behavior disorder (RBD) found that rotigotine transdermal patch improved parkinsonism and subjective sleep quality. It also resulted in reduced severity of RBD symptoms and improved VPSG measures.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

16.

An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson's disease.

Author: WangYan, YangYue-Chang, LanDan-Mei, WuHui -Juan, ZhaoZhong-Xin

Sleep improvement

Rotigotine, a dopamine agonist, may improve sleep quality in patients with Parkinson's disease. This open-label study used video-polysomnography to objectively evaluate the effects of rotigotine on sleep parameters in patients with Parkinson's disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Language : English

17.

Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.

Author: AntoniniA, ChaudhuriK R, BoroojerdiB, AsgharnejadM, BauerL, GriegerF, WeintraubD

ICD behaviors

This study evaluated the frequency of impulse control disorders (ICDs) and other compulsive behaviours reported as adverse events (AEs) in long-term studies of rotigotine transdermal patch in Parkinson's disease (PD).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Language : English

19.

Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.

Author: ChungSun Ju, AsgharnejadMahnaz, BauerLars, RamirezFrancisco, JeonBeomseok

Rotigotine effective
Nausea
Pruritus
Vomiting

Rotigotine did not significantly improve depressive symptoms in patients with Parkinson’s disease.

Clinical Trial, Phase IVPost-marketing surveillance. Monitors long-term safety/efficacy after approval.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

20.

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.

Author: HauserRobert A, SlawekJaroslaw, BaronePaolo, DohinElisabeth, SurmannErwin, AsgharnejadMahnaz, BauerLars

Improved activities of daily living
Improved motor control
No improvement in apathy

Rotigotine did not improve Parkinson's disease-associated apathy, but provided clinically relevant improvement in motor control and activities of daily living.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

21.

Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.

Author: Ferini-StrambiLuigi, MarelliSara, GalbiatiAndrea

Rotigotine for RLS/WED
RLS/WED symptoms

Rotigotine, a long-acting dopamine agonist, is an effective treatment option for severe cases of restless legs syndrome/Willis Ekbom disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

22.

Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.

Author: ZhangZhen-Xin, ShangHui-Fang, HuXingyue, ChenShengdi, ZhaoZhongxin, DuXinlu, SurmannErwin, BauerLars, AsgharnejadMahnaz

Efficacy
Well tolerated

Rotigotine, a dopamine agonist, is effective and well-tolerated in early-stage Parkinson's disease in Chinese patients.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

23.

Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study.

Author: TrenkwalderClaudia, CaneloMonica, LangMichael, SchroederHanna, KellingDaniela, BerkelsReinhard, SchollmayerErwin, HeidbredeTanja, BenesHeike

RLS symptom improvement
Adverse events
Lack of efficacy

Switching from oral dopaminergics to rotigotine transdermal patch for restless legs syndrome (RLS) with augmentation showed improvement in symptoms for a majority of patients. Rotigotine is a promising treatment option for RLS with augmentation, but further research is needed.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

24.

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis.

Author: LeWittPeter A, PoeweWerner, ElmerLawrence W, AsgharnejadMahnaz, BoroojerdiBabak, GriegerFrank, BauerLars

'Off' time reduction

Rotigotine, a transdermal dopamine agonist, shows significant reduction in "off" time for patients with Parkinson's disease.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

25.

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain.

Author: RascolOlivier, ZesiewiczTheresa, ChaudhuriK Ray, AsgharnejadMahnaz, SurmannErwin, DohinElisabeth, NiliusSigrid, BauerLars

Improved pain
Reduced pain severity

Rotigotine, a dopamine agonist, may improve PD-associated pain in patients with advanced Parkinson's disease (PD).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

26.

Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.

Author: Garcia-BorregueroDiego, AllenRichard, HudsonJohn, DohinElisabeth, GriegerFrank, MoranKimberly, SchollmayerErwin, SmitRené, WinkelmanJohn

RLS symptom severity
Application site reactions
Nausea

A double-blind, placebo-controlled study of 150 patients with moderate-to-severe idiopathic restless legs syndrome (RLS) found that rotigotine transdermal patch improved overall RLS symptom severity and RLS symptom severity at various times of the day, but superiority to placebo was not established. Rotigotine was generally well tolerated with the most common adverse events being application site reactions and nausea.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

28.

Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.

Author: SerraoMariano, RanavoloAlberto, ConteCarmela, DavassiChiara, MariSilvia, FasanoAlfonso, ChiniGiorgia, CoppolaGianluca, DraicchioFrancesco, PierelliFrancesco

Improved gait
Increased gait speed
Increased step length
Reduced double support duration

Rotigotine, a dopamine agonist, improved various aspects of gait in patients with Parkinson's disease, including increased step length, gait speed, and cadence, as well as reduced double support duration and step asymmetry.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

29.

Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson's Disease.

Author: HiranoMakito, IsonoChiharu, SakamotoHikaru, UenoShuichi, KusunokiSusumu, NakamuraYusaku

Treats dysphagia

Rotigotine, a dopamine agonist, has been shown to improve swallowing in patients with Parkinson's disease (PD) who experience dysphagia, a potentially fatal symptom that can lead to aspiration pneumonia.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.